Shenzhen Kangtai Biological Products Co Ltd (300601) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.042x

Based on the latest financial reports, Shenzhen Kangtai Biological Products Co Ltd (300601) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥405.44 Million ≈ $59.33 Million USD) by net assets (CN¥9.61 Billion ≈ $1.41 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 300601 stock market capitalisation for the company's overall valuation and market capitalisation.

Shenzhen Kangtai Biological Products Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Shenzhen Kangtai Biological Products Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shenzhen Kangtai Biological Products Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shenzhen Kangtai Biological Products Co Ltd ranked by their cash flow conversion efficiency. Explore Shenzhen Kangtai Biological Products Co earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Hefei Meiya Optoelectronic Technology Inc SHE:002690	0.084x
Test Research Inc TW:3030	0.050x
NGL Energy Partners LP NYSE:NGL	0.022x
WK Kellogg Co NYSE:KLG	0.072x
Stagwell Inc NASDAQ:STGW	0.128x
Ruentex Industries Ltd TW:2915	0.003x
Dgb Financial KO:139130	0.001x
Zenas BioPharma, Inc. Common Stock NASDAQ:ZBIO	-0.224x

Annual Cash Flow Conversion Efficiency for Shenzhen Kangtai Biological Products Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Shenzhen Kangtai Biological Products Co Ltd from 2012 to 2025. View 300601 live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥9.63 Billion ≈ $1.41 Billion	CN¥635.57 Million ≈ $93.00 Million	0.066x	+5.68%
2024-12-31	CN¥9.66 Billion ≈ $1.41 Billion	CN¥603.25 Million ≈ $88.27 Million	0.062x	-42.33%
2023-12-31	CN¥9.54 Billion ≈ $1.40 Billion	CN¥1.03 Billion ≈ $151.18 Million	0.108x	+78.28%
2022-12-31	CN¥8.99 Billion ≈ $1.31 Billion	CN¥545.70 Million ≈ $79.85 Million	0.061x	-66.31%
2021-12-31	CN¥9.17 Billion ≈ $1.34 Billion	CN¥1.65 Billion ≈ $241.78 Million	0.180x	+205.85%
2020-12-31	CN¥7.46 Billion ≈ $1.09 Billion	CN¥439.85 Million ≈ $64.36 Million	0.059x	-67.90%
2019-12-31	CN¥2.75 Billion ≈ $403.03 Million	CN¥505.70 Million ≈ $74.00 Million	0.184x	+0.25%
2018-12-31	CN¥1.84 Billion ≈ $268.83 Million	CN¥336.48 Million ≈ $49.24 Million	0.183x	+27.39%
2017-12-31	CN¥1.07 Billion ≈ $156.72 Million	CN¥153.98 Million ≈ $22.53 Million	0.144x	+34.92%
2016-12-31	CN¥735.00 Million ≈ $107.55 Million	CN¥78.32 Million ≈ $11.46 Million	0.107x	-75.18%
2015-12-31	CN¥647.12 Million ≈ $94.69 Million	CN¥277.85 Million ≈ $40.66 Million	0.429x	+123.70%
2014-12-31	CN¥583.81 Million ≈ $85.43 Million	CN¥112.06 Million ≈ $16.40 Million	0.192x	+170.74%
2013-12-31	CN¥372.17 Million ≈ $54.46 Million	CN¥26.38 Million ≈ $3.86 Million	0.071x	+482.01%
2012-12-31	CN¥431.21 Million ≈ $63.10 Million	CN¥5.25 Million ≈ $768.62K	0.012x	--

About Shenzhen Kangtai Biological Products Co Ltd

SHE:300601 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.99 Billion

CN¥13.57 Billion CNY

Market Cap Rank

#6236 Global

#1220 in China

Share Price

CN¥12.15

Change (1 day)

+3.23%

52-Week Range

CN¥10.97 - CN¥17.50

All Time High

CN¥148.10